Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Top Curr Chem ; 370: 61-112, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26589506

RESUMO

In chemotherapy a fine balance between therapeutic and toxic effects needs to be found for each patient, adapting standard combination protocols each time. Nanotherapeutics has been introduced into clinical practice for treating tumors with the aim of improving the therapeutic outcome of conventional therapies and of alleviating their toxicity and overcoming multidrug resistance. Photodynamic therapy (PDT) is a clinically approved, minimally invasive procedure emerging in cancer treatment. It involves the administration of a photosensitizer (PS) which, under light irradiation and in the presence of molecular oxygen, produces cytotoxic species. Unfortunately, most PSs lack specificity for tumor cells and are poorly soluble in aqueous media, where they can form aggregates with low photoactivity. Nanotechnological approaches in PDT (nanoPDT) can offer a valid option to deliver PSs in the body and to solve at least some of these issues. Currently, polymeric nanoparticles (NPs) are emerging as nanoPDT system because their features (size, surface properties, and release rate) can be readily manipulated by selecting appropriate materials in a vast range of possible candidates commercially available and by synthesizing novel tailor-made materials. Delivery of PSs through NPs offers a great opportunity to overcome PDT drawbacks based on the concept that a nanocarrier can drive therapeutic concentrations of PS to the tumor cells without generating any harmful effect in non-target tissues. Furthermore, carriers for nanoPDT can surmount solubility issues and the tendency of PS to aggregate, which can severely affect photophysical, chemical, and biological properties. Finally, multimodal NPs carrying different drugs/bioactive species with complementary mechanisms of cancer cell killing and incorporating an imaging agent can be developed. In the following, we describe the principles of PDT use in cancer and the pillars of rational design of nanoPDT carriers dictated by tumor and PS features. Then we illustrate the main nanoPDT systems demonstrating potential in preclinical models together with emerging concepts for their advanced design.


Assuntos
Nanopartículas , Neoplasias/terapia , Fotoquimioterapia , Polímeros/química , Humanos
2.
Biomater Adv ; 151: 213484, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37276691

RESUMO

The design of polymeric biocompatible nanomaterials for biological and medical applications has received special attention in recent years. Among different polymers, the triblock type copolymers (EO)x(PO)y(EO)x or Pluronics® stand out due its favorable characteristics such as biocompatibility, low tissue adhesion, thermosensitivity, and structural capacity to produce different types of macro and nanostructures, e.g. micelles, vesicles, nanocapsules, nanospheres, and hydrogels. However, Pluronic itself is not the "magic bullet" and its functionalization via chemical synthesis following biologically oriented design rules is usually required aiming to improve its properties. Therefore, this paper presents some of the main publications on new methodologies for synthetic modifications and applications of Pluronic-based nanoconstructs in the biomedical field in the last 15 years. In general, the polymer modifications aim to improve physical-chemical properties related to the micellization process or physical entrapment of drug cargo, responsive stimuli, active targeting, thermosensitivity, gelling ability, and hydrogel formation. Among these applications, it can be highlighted the treatment of malignant neoplasms, infectious diseases, wound healing, cellular regeneration, and tissue engineering. Functionalized Pluronic has also been used for various purposes, including medical diagnosis, medical imaging, and even miniaturization, such as the creation of lab-on-a-chip devices. In this context, this review discusses the main scientific contributions to the designing, optimization, and improvement of covalently functionalized Pluronics aiming at new strategies focused on the multiple areas of the biomedical field.


Assuntos
Nanoestruturas , Neoplasias , Humanos , Poloxâmero/química , Polímeros/uso terapêutico , Micelas , Nanoestruturas/química
3.
Photochem Photobiol ; 98(1): 175-183, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34309861

RESUMO

Silver nanoparticles (AgNPs) are incredibly versatile nanostructures that more recently have been exploited to create advanced optoelectronic materials due enhancement of local magnetic field after its irradiation. However, the use of AgNPs as nanoantennas to amplify photophysical properties of close photosensitizer (PS) molecules in photodynamic therapy is still underexplored. The reason for that is the difficulty to control crucial parameters such as silver-PS distance in aqueous solution. In this scenario, here we propose a nanohybrid system where AgNP/PS distance is controlled by a thin layer of different Pluronic copolymers. The controllable distance and aqueous stability of proposed nanohybrids allow a tunable enhancement of fluorescence emission and singlet oxygen generation of some selected PS molecules. A detailed mechanism investigation demonstrated that the observed metal-enhanced photophysics is due to magnetic field enhancement close to AgNP surface (AgNP/PS distance-controlled effect) and the resonant coupling of AgNP hot electrons and HOMO-LUMO energies of the PS (AgNP/PS spectral overlap-controlled effect). These results show that the rational design in engineering new nanohybrid structures allowed photophysical improvement of PS molecules in aqueous solution in a tunable way and point out Pluronic-based AgNP/PS nanohybrids as a smart material for further developments aiming at theranostic applications in photodynamic therapy.


Assuntos
Nanopartículas Metálicas , Prata , Nanopartículas Metálicas/química , Fármacos Fotossensibilizantes , Poloxâmero , Polímeros , Prata/química
4.
Mater Sci Eng C Mater Biol Appl ; 114: 110987, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32994027

RESUMO

Nanotechnology development provides new strategies to improve different treatment modalities by integration of multiple molecules in a single multifunctional nanoparticle. In this scenario, we highlight silver nanoparticles (AgNPs) favorable optical properties such as absorption and emission of light in the visible region of the spectrum. This allows its synergic combination with the photosensitizer molecule methylene blue (MB) in order to improve outcomes in photodynamic-based therapies. Therefore, we engineered here a new multifunctional nanostructured system based in the synthesis of pluronic-based AgNP/MB nanohybrids inspired by the concept of supramolecular chemistry. Silver reduction in water and Pluronic F127 aqueous solutions in the presence of hydrogen peroxide as etching agent at several concentrations induced the formation of anisotropic forms of AgNPs. Electronic absorption and TEM studies demonstrated a greater kinetic and morphological control for Pluronic synthetized NPs. The smart design of the proposed nanohybrids favored the enhancement of MB photophysical properties such as fluorescence emission and singlet oxygen production due a synergic action from resonant coupling between AgNP magnetic field and MB molecules. Results also demonstrated that AgNP-MB distance modulation in Pluronic matrix is a relevant parameter in MB photophysical improvement. Finally, since AgNP absorbance spectrum is dependent on AgNP shape, it plays a critical role in the improvement of MB photophysical properties. These results show that the rational design in engineering new multifunctional nanoparticles is essential and point out that Pluronic AgNP/MB nanohybrids as a smart material for further developments aiming photodynamic-based therapies.


Assuntos
Nanopartículas Metálicas , Fotoquimioterapia , Azul de Metileno , Poloxâmero , Prata
5.
Mater Sci Eng C Mater Biol Appl ; 104: 109923, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31499973

RESUMO

The high incidence of cancer, necessity of treatment, and prognosis times are urgent issues that need to be addressed. In this work, we present DPPC liposomes coated with F127 triblock copolymers as a promising alternative in drug delivery systems for cancer therapy. The proposed mixed liposomes exhibit adequate size, high stability, and passive targeting that result from the EPR effect. An interesting strategy to obtain both passive and active targeting is the vectorization with a covalent bond between F127 and Biotin (a vitamin). Cancer cells can overexpress Biotin receptors, such as Avidin. Here, we evaluate the cytotoxic effects of the erythrosine-decyl ester (ERYDEC). This is a photosensitizer that can be utilized in photodynamic therapy (PDT) and incorporated in DPPC liposomes coated with F127 (F127/DPPC) and the biotinylated-F127 (F127-B/DPPC). The results showed that DPPC liposomes were efficiently mixed with common F127 or F127B, exhibiting adequate physical properties with simple and low-cost preparation. An HABA/Avidin assay showed the amount of Biotin available at the liposome surface. In addition, ERYDEC interaction with lipid vesicles showed high encapsulating efficiency and slow release kinetics. The ERYDEC monomeric species are represented by high light absorption and high singlet oxygen generation (1O2), which confirm the presence of the drug in its monomeric state, as required for PDT. The ERYDEC/liposome system showed high stability and absence of significant cytotoxic effects (absence of light) in fibroblasts of the Mus musculus cell line. In addition, phototoxicity studies showed that ERYDEC/liposomes were able to inhibit cancer cells. However, in the biotinylated system, the effect was much greater than the common F127 coating. This dramatically decreased the inhibitory concentration of CC50 and CC90. In addition, cellular uptake studies based on fluorescence properties of ERYDEC showed that a two-hour incubation period was enough for the uptake by the cell. Therefore, the new vectorized-coated liposome is a potential system for use in cancer treatments, considering that it is a theranostic platform.


Assuntos
Biotina/química , Liberação Controlada de Fármacos , Fármacos Fotossensibilizantes/farmacologia , Animais , Biotinilação , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Eritrosina/farmacologia , Humanos , Hidrodinâmica , Lipossomos , Tamanho da Partícula , Fotoquimioterapia , Fármacos Fotossensibilizantes/química , Poloxâmero/química , Espectrofotometria Ultravioleta
6.
Eur J Pharm Biopharm ; 130: 30-38, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29890256

RESUMO

In this paper, we shed light on the potential of Pluronic® mixed micelles in lung delivery of poorly water-soluble drugs. To this purpose, Pluronic® P123/F127 mixed micelles (PMM), exhibiting superior stability in biological fluids, were loaded with budesonide (BUD), a model hydrophobic corticosteroid, and fully investigated focusing on their stability in pulmonary-relevant media, transport through the mucus barrier and aerodynamic behaviour in vitro. Then, lung bio-distribution and efficacy were evaluated in vivo, after intra-tracheal administration in rats. PMM showed excellent stability in saline, mucin, artificial airway mucus and simulated interstitial lung fluid. Likely due to their small size coupled with the hydrophilic biofouling shell, PMM did not interact with mucin and consequently diffused through artificial mucus. BUD was loaded with high efficiency in PMM and released at sustained rate in artificial mucus. BUD-PMM dispersion in saline was efficiently delivered through a common jet nebulizer without aggregation. After intratracheal administration in rats, PMM labelled with Rhodamine B persisted in the lung up to 24 h, while serum levels rapidly dropped. Finally, the effects of BUD-PMM in a rat model of lung inflammation induced by intra-tracheal aerosolization of lipopolysaccharide (LPS) from E. coli were investigated. Of note, a single intra-tracheal aerosolization of BUD-PMM significantly reduced bronchoalveolar neutrophil infiltration and the expression of protein/enzymes derived from the arachidonic acid cascade induced by LPS, whereas a control BUD aqueous suspension showed a weaker effect. Overall, this study demonstrates that inhalable formulations of PMM can be considered as a platform for local delivery of hydrophobic drugs at lungs worth of further consideration.


Assuntos
Budesonida/administração & dosagem , Sistemas de Liberação de Medicamentos , Pulmão/metabolismo , Poloxâmero/química , Administração por Inalação , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacocinética , Budesonida/química , Budesonida/farmacocinética , Modelos Animais de Doenças , Portadores de Fármacos/química , Interações Hidrofóbicas e Hidrofílicas , Lipopolissacarídeos/toxicidade , Masculino , Micelas , Nebulizadores e Vaporizadores , Tamanho da Partícula , Pneumonia/tratamento farmacológico , Ratos , Ratos Wistar , Fatores de Tempo , Distribuição Tecidual
7.
Mater Sci Eng C Mater Biol Appl ; 71: 1-9, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-27987651

RESUMO

Nanotechnology development provides new strategies to treat cancer by integration of different treatment modalities in a single multifunctional nanoparticle. In this scenario, we applied the multifunctional Pluronic P123/F127 mixed micelles for Verteporfin-mediated photodynamic therapy in PC3 and MCF-7 cancer cells. Micelles functionalization aimed the targeted delivery by the insertion of biotin moiety on micelle surface and fluorescence image-based through rhodamine-B dye conjugation in the polymer chains. Multifunctional Pluronics formed spherical nanoparticulated micelles that efficiently encapsulated the photosensitizer Verteporfin maintaining its favorable photophysical properties. Lyophilized formulations were stable at least for 6months and readily reconstituted in aqueous media. The multifunctional micelles were stable in protein-rich media due to the dual Pluronic mixed micelles characteristic: high drug loading capacity provided by its micellar core and high kinetic stability due its biocompatible shell. Biotin surface functionalized micelles showed higher internalization rates due biotin-mediated endocytosis, as demonstrated by competitive cellular uptake studies. Rhodamine B-tagged micelles allowed monitoring cellular uptake and intracellular distribution of the formulations. Confocal microscopy studies demonstrated a larger intracellular distribution of the formulation and photosensitizer, which could drive Verteporfin to act on multiple cell sites. Formulations were not toxic in the dark condition, but showed high Verteporfin-induced phototoxicity against both cancer cell lines at low drug and light doses. These results point Verteporfin-loaded multifunctional micelles as a promising tool to further developments in photodynamic therapy of cancer.


Assuntos
Portadores de Fármacos , Micelas , Nanopartículas/química , Neoplasias/tratamento farmacológico , Fotoquimioterapia , Poloxaleno , Poloxâmero , Porfirinas , Nanomedicina Teranóstica/métodos , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacologia , Feminino , Humanos , Células MCF-7 , Masculino , Neoplasias/metabolismo , Neoplasias/patologia , Poloxaleno/química , Poloxaleno/farmacocinética , Poloxaleno/farmacologia , Poloxâmero/química , Poloxâmero/farmacocinética , Poloxâmero/farmacologia , Porfirinas/química , Porfirinas/farmacocinética , Porfirinas/farmacologia , Verteporfina
8.
Photodiagnosis Photodyn Ther ; 15: 127-32, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27375182

RESUMO

BACKGROUND: Photodynamic inactivation of microorganisms is based on a photosensitizing substance which, in the presence of light and molecular oxygen, produces singlet oxygen, a toxic agent to microorganisms and tumor cells. This study aimed to evaluate singlet oxygen quantum yield of erythrosine solutions illuminated with a halogen light source in comparison to a LED array (control), and the photodynamic effect of erythrosine dye in association with the halogen light source on Streptococcus mutans. METHODS: Singlet oxygen quantum yield of erythrosine solutions was quantified using uric acid as a chemical-probe in an aqueous solution. The in vitro effect of the photodynamic antimicrobial activity of erythrosine in association with the halogen photopolimerizing light on Streptococcus mutans (UA 159) was assessed during one minute. Bacterial cultures treated with erythrosine alone served as negative control. RESULTS: Singlet oxygen with 24% and 2.8% degradation of uric acid in one minute and a quantum yield of 0.59 and 0.63 was obtained for the erythrosine samples illuminated with the halogen light and the LED array, respectively. The bacterial cultures with erythrosine illuminated with the halogen light presented a decreased number of CFU mL(-1) in comparison with the negative control, with minimal inhibitory concentrations between 0.312 and 0.156mgmL(-1). CONCLUSIONS: The photodynamic response of erythrosine induced by the halogen light was capable of killing S. mutans. Clinical trials should be conducted to better ascertain the use of erythrosine in association with halogen light source for the treatment of dental caries.


Assuntos
Lâmpadas de Polimerização Dentária , Eritrosina/administração & dosagem , Iluminação/instrumentação , Fotoquimioterapia/instrumentação , Oxigênio Singlete/administração & dosagem , Streptococcus mutans/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos da radiação , Desinfecção/instrumentação , Desinfecção/métodos , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Quimioterapia Combinada/métodos , Humanos , Luz , Iluminação/métodos , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/administração & dosagem , Oxigênio Singlete/efeitos da radiação , Streptococcus mutans/citologia , Streptococcus mutans/fisiologia , Resultado do Tratamento
9.
Int J Pharm ; 511(1): 127-139, 2016 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-27374195

RESUMO

With the aim to develop alternative therapeutic tools for the treatment of resistant cancers, here we propose targeted Pluronic(®) P123/F127 mixed micelles (PMM) delivering niclosamide (NCL) as a repositioning strategy to treat multidrug resistant non-small lung cancer cell lines. To build multifunctional PMM for targeting and imaging, Pluronic(®) F127 was conjugated with biotin, while Pluronic(®) P123 was fluorescently tagged with rhodamine B, in both cases at one of the two hydroxyl end groups. This design intended to avoid any interference of rhodamine B on biotin exposition on PMM surface, which is a key fundamental for cell trafficking studies. Biotin-decorated PMM were internalized more efficiently than non-targeted PMM in A549 lung cancer cells, while very low internalization was found in NHI3T3 normal fibroblasts. Biotin-decorated PMM entrapped NCL with good efficiency, displayed sustained drug release in protein-rich media and improved cytotoxicity in A549 cells as compared to free NCL (P<0.01). To go in depth into the actual therapeutic potential of NCL-loaded PMM, a cisplatin-resistant A549 lung cancer cell line (CPr-A549) was developed and its multidrug resistance tested against common chemotherapeutics. Free NCL was able to overcome chemoresistance showing cytotoxic effects in this cell line ascribable to nucleolar stress, which was associated to a significant increase of the ribosomal protein rpL3 and consequent up-regulation of p21. It is noteworthy that biotin-decorated PMM carrying NCL at low doses demonstrated a significantly higher cytotoxicity than free NCL in CPr-A549. These results point at NCL-based regimen with targeted PMM as a possible second-line chemotherapy for lung cancer showing cisplatin or multidrug resistance.


Assuntos
Biotina/administração & dosagem , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Neoplasias Pulmonares , Niclosamida/administração & dosagem , Poloxaleno/administração & dosagem , Poloxâmero/administração & dosagem , Células A549 , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/metabolismo , Biotina/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Relação Dose-Resposta a Droga , Sistemas de Liberação de Medicamentos/métodos , Resistencia a Medicamentos Antineoplásicos/fisiologia , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/metabolismo , Camundongos , Micelas , Células NIH 3T3 , Niclosamida/metabolismo , Poloxaleno/metabolismo , Poloxâmero/metabolismo , Proteína Ribossômica L3
10.
Photochem Photobiol ; 92(6): 790-799, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27716938

RESUMO

It was evaluated the properties of the xanthene dyes Erythrosin B, Eosin Y and theirs Methyl, Butyl and Decyl ester derivatives as possible photosensitizers (PS) for photodynamic treatments. The more hydrophobic dyes self-aggregate in water/ethanol solutions above 70% water (vol/vol) in the mixture. In buffered water, these PS were encapsulated in Pluronic polymeric surfactants of P-123 and F-127 by two methodologies: direct addition and the thin-film solid dispersion methods. The thin-film solid method provided formulations with higher stabilities besides effective encapsulation of the PS as monomers. Size measurements demonstrated that Pluronic forms self-assembled micelles with uniform size, which present slightly negative surface potential and a spherical form detected by TEM microscopy. The ester length modulates xanthene localization in the micelle, which is deeper with the increase in the alkyl chain. Moreover, some PS are distributed into two populations: one on the corona micelle interface shell (PEO layer) and the other into the core (PPO region). Although all PS formulations show high singlet oxygen quantum yield, promising results were obtained for Erythrosin B esters with the hydrophobic P-123, which ensures their potential as drug for clinical photodynamic applications.


Assuntos
Corantes , Micelas , Nanoestruturas/química , Fármacos Fotossensibilizantes , Polímeros/química , Xantenos/química , Corantes/química , Corantes/farmacologia , Estabilidade de Medicamentos , Etanol/química , Microscopia Eletrônica de Transmissão , Fotoquimioterapia , Fármacos Fotossensibilizantes/química , Poloxâmero/análogos & derivados , Poloxâmero/química , Água/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA